Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase

a technology of adenylate cyclase and bordetella sp., which is applied in the field of recombinant adenylate cyclase of bordetella sp. for diagnostic and immunomonitoring, can solve the problems of significant animal welfare, economic and potential public health problems, and limited specificity of this test, and achieves enhanced t cell responses

Inactive Publication Date: 2006-01-26
INST PASTEUR
View PDF3 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0019] This invention aids in fulfilling the needs in the art by providing immunodiagnostic methods, especially immunodiagnostic methods carried out in vitro, that allow for enhanced T cell responses to M. tuberculosis, more particularly, this invention provides a novel system for diagnostic testing and immunomonitoring that uses genetically detoxified Bordetella sp. CyaA as a delivery system.
[0020] The invention provides methods of diagnostic testing and immunomonitoring with peptides genetically fused or chemically bound to CyaA. The results of tests with recombinant CyaA are quantitative and, therefore, can provide immunomonitoring, as well as simple diagnostic testing.

Problems solved by technology

This increase constitutes a significant animal welfare, economic, and potential public health problem (Krebs et al., 1997).
The specificity of this test is limited because of the undefined and cross-reactive nature of PPD.
M. tuberculosis is also a major threat to human health, being responsible for more deaths globally than any other bacterium.
The vaccine against, and immunological diagnosis of, TB are not fully satisfactory.
Bacille Calmette Guerin (BCG) vaccine is very widely used to prevent TB, but its protective efficacy in adults is also limited.
One aspect of this control strategy is diagnostic testing, but the tuberculin skin test (TST), used to identify healthy individuals with latent infection, has several operational drawbacks.
These limitations impair identification of LTBI and, therefore, wider application of PT.
However, protein subunits tend to inefficiently stimulate T cell responses and even the most promising experimental vaccine preparations require powerful adjuvants that are not licensed for use in humans.
Similarly, the best immunodiagnostic methods previously known rely on peptide mixtures and ELISPOT analysis that are likely too complex for use in medically-underserved environments (Arend, S. M., et al.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
  • Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
  • Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase

Examples

Experimental program
Comparison scheme
Effect test

example 1

Materials and Methods for Bovine Studies

[0089] Bovine (PPD-B) and avian (PPD-A) tuberculin were obtained from the Tuberculin Production Unit at the Veterinary Laboratories Agency—Weybridge and used in culture at 10 μg / ml. Recombinant ESAT-6 was supplied by Dr. A. Whelan (VLA Weybridge), recombinant CFP-10 was obtained from Lionex Ltd., Braunschweig, Germany. CyaA, CyaA-CFP-10, and CyaA-ESAT-6 was provided by Dr. C. Leclerc, Institut Pasteur, Paris. Identical batches of proteins were used throughout.

[0090]M. bovis infected cattle (Vordermeier et al., 1999) Calves were infected with a M. bovis field strain from GB (AF 2122 / 97) by intratracheal instillation of between 5×103 and 5×104 CFU. Infection was confirmed by the presence of tuberculous lesions in the lungs and lymph nodes of these animals as well as by the culture of M. bovis from tissue collected at the post-mortems performed approximately 20 weeks after the infection. Heparinized blood samples were obtained at least six week...

example 2

Construction and Purification of Recombinant CyaA Carrying Entire Mycobacterial Antigens Cfp10 or Esat-6

[0096]Escherichia coli XL1-Blue (Stratagene) was used for recombinant DNA construction and for expression of antigens inserted into CyaA. Bacteria transformed with appropriate plasmids derived from pT7CACT1 (Osicka et al., 2000) were grown at 37° C. in Luria-Bertani medium supplemented with 150 μg of ampicillin per ml. The open reading frames of Mycobacterium tuberculosis H37Rv genes esat-6 and cfp-10 were amplified by PCR from the pYUB412 cosmid clone of the RD1 region (Gordon et al., 1999) using the following primers:

(SEQ ID NO: 1)Esat6-I5′-GATGTGTACACATGACAGAGCAGCAGTGG-3′(SEQ ID NO: 2)Esat6-II5′-GATGTGTACACTGAGCGAACATCCCAGTGACG-3′(SEQ ID NO: 3)CFP-10-I5′-CATGTGTACACATGGCAGAGATGAAGACC-3′(SEQ ID NO: 4)CFP-10-II5′-CATGTGTACACTGAAGCCCATTTGCGAGGA-3′.

[0097] The PCR product was digested by BsrG I at the sites incorporated into the PCR primers and the purified fragments encoding the...

example 3

IFN-γ Responses of Experimentally Infected Cattle

[0099] PBMC were prepared from experimentally infected cattle and incubated with serial dilutions of antigens (recombinant ESAT-6, CFP-10, CyaA-ESAT6, CyaA-CFP10, and CyaA control). The antigen-induced IFN-γ responses were determined after 24 h culture using a sensitive ELISPOT assay. The number of spot-forming cells (SFC) found without antigen added (medium controls) were subtracted, the number of SFC obtained after CyaA stimulation were subtracted from the number of SFC induced after CyaA-ESAT6 and CyaA-CFP10 stimulation. To illustrate how the data were subsequently expressed and compared, a representative result for CFP-10 tested in one calf is given in FIG. 1. In this calf, CyaA-CFP-10 induced both a higher peak response than recombinant CFP-10 (as shown by comparison of values indicated by horizontal lines a and b), and was recognized more effectively as indicated by the vertical lines d and e, which indicate the concentrations ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Diagnostic testing and immunomonitoring that uses genetically detoxified Bordetella pertussis CyaA as a delivery system are effective in tracking any immune responses, such as those generated by infectious and non-infectious diseases, or vaccinations, for example. T cells previously stimulated by a given antigen can be restimulated in vitro by the same antigen fused or chemically coupled to CyaA or a fragment thereof. The invention includes diagnostic tests and immunomonitoring for tuberculosis by providing a delivery system, which can deliver the M. tuberculosis immunodominant proteins ESAT-6 and CFP-10, to human cells and non-human animal cells, such as cattle. In addition, fusion proteins between CyaA and cancer antigens are also provided as diagnostic tests and immunomonitoring systems for cancers, such as melanoma.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] The application claims the benefit of priority of U.S. Provisional Application No. 60 / 523,704 (attorney docket number 03495-6094), filed Nov. 21, 2003, which is incorporated herein by reference.FIELD OF THE INVENTION [0002] The invention relates to recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring. BACKGROUND OF THE INVENTION [0003] This invention relates to diagnostic testing and immunomonitoring of diseases, as well as immunomonitoring of any T cell response following stimulation of T cells by an antigen. [0004] The incidence of tuberculosis (TB) in cattle, caused by Mycobacterium bovis, has dramatically increased over the last decades in the British national herd. This increase constitutes a significant animal welfare, economic, and potential public health problem (Krebs et al., 1997). To control this zoonotic disease, better and more specific diagnostic reagents, as well as effective vaccines, are u...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/554G01N33/569G01N33/50
CPCC12Q1/527G01N33/505G01N2333/988G01N33/6893G01N2333/235G01N33/5695
Inventor LECLERC, CLAUDEMAJLESSI, LALEHSCHLECHT-LOUF, GERALDINESEBO, PETERSIMSOVA, MARCELAVORDERMEIER, MARTINWILKINSON, ROBERTSCHOLVINCK, ELISABETHLOUCKA, JIRINA
Owner INST PASTEUR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com